ZQX-15691-83536
4 vaccinations
8 coded responses
20 check-ins
7 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 481 / MI
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
- 2021-01-06
- 2021-01-07
-
2021-01-08
Survey response — days 1–6 daily, dose 1MedDRA: Heart rate irregular — Feeling: Good · Abdominal painMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-21
-
2021-01-27
Dose 2 — Pfizer-BioNTech
-
2021-02-03
Survey response — 7 day, dose 2MedDRA: Gastrooesophageal reflux disease — Feeling: Good · Muscle or body aches, Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-02-10
Survey response — 14 day, dose 2MedDRA: Condition aggravated, Gastrooesophageal reflux disease, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-17
- 2021-02-24
-
2021-03-03
Survey response — 35 day, dose 2MedDRA: Pain — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-10
Survey response — 42 day, dose 2MedDRA: Formication, Pain — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-04-28
- 2021-07-30
-
2021-11-16
Dose 3 — Moderna
-
2022-01-27
Survey response — 12 month, dose 2MedDRA: Gastrointestinal disorder — Feeling: FairMedDRA releases: 2024-11 · check-in answers available
-
2022-09-07
Dose 4 — Moderna
-
2022-09-22
Survey response — 14 day, dose 4MedDRA: Urine output increased — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2022-09-22
Report sent to call center — 14 day, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-09-23
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-03-08
Survey response — 6 month, dose 4MedDRA: Blood glucose increased, Blood thyroid stimulating hormone increased, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2023-03-08
Report sent to call center — 6 month, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-09
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech | |
| 3 | 2021-11-16 | Moderna | No |
| 4 | 2022-09-07 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-22 | Successful 2022-09-23 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-03-08 | Successful 2023-03-09 |
Participant prefers to complete VAERS report online |
Free text
Release 1
Systemic reaction (other): Occasinal ectopic heart beat
Release 3
Systemic reaction (other): Acid Reflux
Release 4
Symptoms: Never had acid reflux symptoms before, and I started having reflux issue right after 2nd dose. I dont think it is related to vaccine and is most likely coincidental. I also have preexisting spine-related pain/neurological issues which has worsened. cut off by CDC
Release 5
Symptoms: Increased Pain
Symptoms: Pain, creeping and crawling sensations
Release 11
Symptoms: Gastrointestinal symptoms.
Release 12
Symptoms: Increased urine output volume.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood glucose increased | · | · | ✓ |
| SD | Blood thyroid stimulating hormone increased | · | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Formication | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Urine output increased | · | · | ✓ |
| SRO | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SRO | Heart rate irregular | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release